Ameriprise Financial Inc View Ray, Inc. Transaction History

Ameriprise Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.35 - $3.28 $90,696 - $849,956	259,133 Added 875.45%	288,733 $101,000
Q4 2022 Feb 14, 2023	BUY	$3.65 - $4.82 $5,475 - $7,230	1,500 Added 5.34%	29,600 $132,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $3.97 $35,378 - $52,801	13,300 Added 89.86%	28,100 $102,000
Q1 2022 May 16, 2022	BUY	$3.45 - $5.83 $51,060 - $86,284	14,800 New	14,800 $58,000
Q4 2019 Feb 14, 2020	SELL	$2.3 - $4.6 $54,967 - $109,935	-23,899 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.9 - $9.56 $69,307 - $228,474	23,899 New	23,899 $70,000
Q1 2018 May 15, 2018	SELL	$6.26 - $10.12 $1.01 Million - $1.63 Million	-161,202 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$5.6 - $9.9 $902,731 - $1.6 Million	161,202	161,202 $1.49 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.